Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert S. Langer, Sc.D.

Co-Author

This page shows the publications co-authored by Robert Langer and Joseph Vacanti.
Connection Strength

2.737
  1. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet. 1999 Jul; 354 Suppl 1:SI32-4.
    View in: PubMed
    Score: 0.217
  2. Tissue engineering: the challenges ahead. Sci Am. 1999 Apr; 280(4):86-9.
    View in: PubMed
    Score: 0.213
  3. Artificial organs. Sci Am. 1995 Sep; 273(3):130-3.
    View in: PubMed
    Score: 0.166
  4. Tissue engineering. Science. 1993 May 14; 260(5110):920-6.
    View in: PubMed
    Score: 0.142
  5. Progress in tissue engineering. Sci Am. 2009 May; 300(5):64-71.
    View in: PubMed
    Score: 0.107
  6. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg. 1988 Jan; 23(1 Pt 2):3-9.
    View in: PubMed
    Score: 0.098
  7. Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A. 2006 Feb 21; 103(8):2480-7.
    View in: PubMed
    Score: 0.086
  8. Effect of implantation site on hepatocytes heterotopically transplanted on biodegradable polymer scaffolds. Tissue Eng. 2003 Dec; 9(6):1227-32.
    View in: PubMed
    Score: 0.074
  9. Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation. 2002 May 27; 73(10):1589-93.
    View in: PubMed
    Score: 0.066
  10. Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev. 1998 08 03; 33(1-2):165-182.
    View in: PubMed
    Score: 0.051
  11. Formation of spheroidal aggregates of hepatocytes on biodegradable polymers under continuous-flow bioreactor conditions. Eur J Pediatr Surg. 1998 Aug; 8(4):195-9.
    View in: PubMed
    Score: 0.051
  12. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res. 1997 Dec 05; 37(3):413-20.
    View in: PubMed
    Score: 0.049
  13. Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci U S A. 1997 Aug 19; 94(17):8948-53.
    View in: PubMed
    Score: 0.048
  14. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg. 1997 Mar; 11(3):493-7.
    View in: PubMed
    Score: 0.046
  15. Enhanced survival of transgenic hepatocytes expressing hepatocyte growth factor in hepatocyte tissue engineering. Transplant Proc. 1997 Feb-Mar; 29(1-2):858-60.
    View in: PubMed
    Score: 0.046
  16. The effect of donor and recipient age on engraftment of tissue-engineered liver. J Pediatr Surg. 1997 Feb; 32(2):357-60.
    View in: PubMed
    Score: 0.046
  17. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials. 1996 Jul; 17(14):1417-22.
    View in: PubMed
    Score: 0.044
  18. Tissue engineering lamb heart valve leaflets. Biotechnol Bioeng. 1996 Jun 05; 50(5):562-7.
    View in: PubMed
    Score: 0.044
  19. Chondrogenesis by bone marrow-derived mesenchymal stem cells grown in chondrocyte-conditioned medium for auricular reconstruction. J Tissue Eng Regen Med. 2017 10; 11(10):2763-2773.
    View in: PubMed
    Score: 0.044
  20. Regenerative signals for heterotopic hepatocyte transplantation. Transplant Proc. 1996 Jun; 28(3):1857-8.
    View in: PubMed
    Score: 0.044
  21. Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes. Biotechnol Bioeng. 1996 May 20; 50(4):422-9.
    View in: PubMed
    Score: 0.044
  22. Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials. 1996 Jan; 17(2):115-24.
    View in: PubMed
    Score: 0.043
  23. Biodegradable sponges for hepatocyte transplantation. J Biomed Mater Res. 1995 Aug; 29(8):959-65.
    View in: PubMed
    Score: 0.041
  24. Dynamics of fibrovascular tissue ingrowth in hydrogel foams. Cell Transplant. 1995 May-Jun; 4(3):275-9.
    View in: PubMed
    Score: 0.041
  25. Hepatocyte transplantation in biodegradable polymer scaffolds using the Dalmatian dog model of hyperuricosuria. Transplant Proc. 1995 Feb; 27(1):635-6.
    View in: PubMed
    Score: 0.040
  26. Fabricating tubular devices from polymers of lactic and glycolic Acid for tissue engineering. Tissue Eng. 1995; 1(2):107-18.
    View in: PubMed
    Score: 0.040
  27. Tissue engineering: biomedical applications. Tissue Eng. 1995; 1(2):151-61.
    View in: PubMed
    Score: 0.040
  28. Transplantation of hepatocytes using porous, biodegradable sponges. Transplant Proc. 1994 Dec; 26(6):3425-6.
    View in: PubMed
    Score: 0.039
  29. Tracheal composites tissue engineered from chondrocytes, tracheal epithelial cells, and synthetic degradable scaffolding. Transplant Proc. 1994 Dec; 26(6):3309-10.
    View in: PubMed
    Score: 0.039
  30. The mesentery as a laminated vascular bed for hepatocyte transplantation. Cell Transplant. 1994 Jul-Aug; 3(4):273-81.
    View in: PubMed
    Score: 0.038
  31. Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant. 1994 Mar-Apr; 3(2):203-10.
    View in: PubMed
    Score: 0.037
  32. Prevascularization of porous biodegradable polymers. Biotechnol Bioeng. 1993 Sep 05; 42(6):716-23.
    View in: PubMed
    Score: 0.036
  33. Cell transplantation of genetically altered cells on biodegradable polymer scaffolds in syngeneic rats. Transplantation. 1993 Aug; 56(2):423-7.
    View in: PubMed
    Score: 0.036
  34. Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials. 1993 Apr; 14(5):323-30.
    View in: PubMed
    Score: 0.035
  35. Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res. 1993 Feb; 27(2):183-9.
    View in: PubMed
    Score: 0.035
  36. Transplantation of genetically altered hepatocytes using cell-polymer constructs. Transplant Proc. 1993 Feb; 25(1 Pt 2):1002-4.
    View in: PubMed
    Score: 0.035
  37. Cell seeding in porous transplantation devices. Biomaterials. 1993; 14(4):270-8.
    View in: PubMed
    Score: 0.035
  38. Design of synthetic polymeric structures for cell transplantation and tissue engineering. Clin Mater. 1993; 13(1-4):3-10.
    View in: PubMed
    Score: 0.035
  39. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg. 1991 Nov; 88(5):753-9.
    View in: PubMed
    Score: 0.032
  40. Hepatocyte culture on biodegradable polymeric substrates. Biotechnol Bioeng. 1991 Jun 20; 38(2):145-58.
    View in: PubMed
    Score: 0.031
  41. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng. 1991 May; 113(2):143-51.
    View in: PubMed
    Score: 0.031
  42. Studies in rat liver perfusion for optimal harvest of hepatocytes. J Pediatr Surg. 1990 Jan; 25(1):140-4; discussion 144-5.
    View in: PubMed
    Score: 0.028
  43. Nanofabricated collagen-inspired synthetic elastomers for primary rat hepatocyte culture. Tissue Eng Part A. 2009 Jun; 15(6):1321-9.
    View in: PubMed
    Score: 0.027
  44. A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc Natl Acad Sci U S A. 2008 Feb 19; 105(7):2307-12.
    View in: PubMed
    Score: 0.025
  45. Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials. 2005 Sep; 26(27):5454-64.
    View in: PubMed
    Score: 0.021
  46. Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng. 2005 Jan-Feb; 11(1-2):302-9.
    View in: PubMed
    Score: 0.020
  47. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials. 2000 Sep; 21(18):1837-45.
    View in: PubMed
    Score: 0.015
  48. In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials. 2000 Aug; 21(15):1595-605.
    View in: PubMed
    Score: 0.015
  49. Control of tumor growth in animals by infusion of an angiogenesis inhibitor. Proc Natl Acad Sci U S A. 1980 Jul; 77(7):4331-5.
    View in: PubMed
    Score: 0.015
  50. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg. 1999 Dec; 68(6):2298-304; discussion 2305.
    View in: PubMed
    Score: 0.014
  51. A tissue-engineered conduit for peripheral nerve repair. Arch Otolaryngol Head Neck Surg. 1998 Oct; 124(10):1081-6.
    View in: PubMed
    Score: 0.013
  52. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg. 1998 Mar; 115(3):536-45; discussion 545-6.
    View in: PubMed
    Score: 0.012
  53. Tissue-engineered heart valve leaflets: does cell origin affect outcome? Circulation. 1997 Nov 04; 96(9 Suppl):II-102-7.
    View in: PubMed
    Score: 0.012
  54. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation. 1996 Nov 01; 94(9 Suppl):II164-8.
    View in: PubMed
    Score: 0.011
  55. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg. 1995 Dec; 60(6 Suppl):S513-6.
    View in: PubMed
    Score: 0.011
  56. Generation of neo-tendon using synthetic polymers seeded with tenocytes. Transplant Proc. 1994 Dec; 26(6):3390-2.
    View in: PubMed
    Score: 0.010
  57. Extracellular matrix controls tubulin monomer levels in hepatocytes by regulating protein turnover. Mol Biol Cell. 1994 Dec; 5(12):1281-8.
    View in: PubMed
    Score: 0.010
  58. Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytes. Biomaterials. 1994 Aug; 15(10):774-8.
    View in: PubMed
    Score: 0.010
  59. Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol. 1992 Jun; 151(3):497-505.
    View in: PubMed
    Score: 0.008
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.